Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome
A medical consultation is required to determine eligibility, safety, and the most appropriate treatment plan for you
Long-Term Safety Considerations As a relatively new class of medications, the long-term safety profile of GLP-1 agonists is still under evaluation
Improved insulin sensitivity can influence sex hormone-binding globulin (SHBG) levels, which determines how much free testosterone and estrogen circulate in the blood
Previous analysis of trials into the efficacy of different diets, not including drugs, by the same researchers, found that while people also regained weight after stopping diets, the rate of regain was much slower, taking at least five years to get back to the weight they were before
Buyer Takeaway: The regulatory outcome is uncertain as of June 2026 but is likely to restrict large-scale compounded GLP-1 availability
US$ 24.65
US$ 22.84
US$ 22.06
